(Q38393727)

English

Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF).

scientific article published on December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

multicenter clinical trial

0 references

0 references

author name string

Christiane E Angermann

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Götz Gelbrich

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Stefan Störk

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Andreas Fallgatter

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jürgen Deckert

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Hermann Faller

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Georg Ertl

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

MOOD-HF Investigators

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1212-1222

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Depression and anxiety in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Relationship of depression to death or hospitalization in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Depression, the autonomic nervous system, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Depression, alterations in platelet function, and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

The role of immune system parameters in the relationship between depression and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Sertraline treatment of major depression in patients with acute MI or unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Effects of antidepressant treatment following myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

An extended Kaplan-Meier estimator and its applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Cognitive impairment: a key feature of congestive heart failure in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Responsiveness of the PHQ-9 to Psychopharmacological Depression Treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

A brief measure for assessing generalized anxiety disorder: the GAD-7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.10.005

21 January 2018

Identifiers

10.1016/J.EJHEART.2007.10.005

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38393727&oldid=1509241667"